Brazil Oncology Drugs Market Analysis


  • Type: Therapeutics Area
  • Published : February 2022
  • Region: LATAM
  • Country: Brazil
  • Report ID : 5069

  • Format: PPT, PDF

Brazil Oncology Drugs Market: Segmented by Therapy Type, Cancer Type, and Distribution Channel Type – Growth, Market Size, Future Prospects & Competitive Analysis, 2021 – 2027

SKU: 5069 Categories: ,

Report Description of the Brazil Oncology Drugs Market

Research Scope and Assumption

  • The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
  • The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
  • We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
  • All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
  • Inflation has not been accounted for in order to estimate and forecast the market
  • Numbers may not add up due to rounding off

Research Objective:

  • To analyze and forecast the market size of Brazil Oncology Drugs Drugs market
  • To classify and forecast Brazil Oncology Drugs Market market based on application, drugs, project type, and application.
  • To identify drivers and challenges for Brazil Oncology Drugs market
  • To examine competitive developments such as mergers and acquisitions, agreements, collaborations and partnerships, etc., in Brazil Oncology Drugs market
  • To conduct pricing analysis for Brazil Oncology Drugs Drugs market
  • To identify and analyze the profile of leading players operating in Brazil Oncology Drugs market

Reason to buy the report:

  • Facilitate decision-making based on strong current and forecast data for Atopic Dermatitis drug market
  • Develop strategies based on the latest regulatory framework
  • Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
  • Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the Atopic Dermatitis market
  • Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • We have technically sound team which do a deep dive research and also provide strategy-based consulting analysis

Brazil Oncology Drugs Market Executive Summary

The risk of getting cancer before the age of 75 is around 9.5% in Brazil. According to a survey carried out by the National Cancer Institute (Inca), approximately 600,000 new cases of cancer will appear in the country last year, which makes it a huge emerging market.

Market Size and Key Findings

The Brazil Oncology Drugs market size is at around USD 7.9  billion in 2020 and is projected to reach USD xx billion in 2027, exhibiting a CAGR of 10.9% during the forecast period.

The major cases of oncology in the country are seen in prostate, breast, colorectum, lung, thyroid and others. Among these, prostate constitutes the major portion of the cases. Due to this, government has mandated few guidelines, to detect cases in its earlier stages. Thus, the growing incidence and prevalence of cancer are likely to drive the growth of the Oncology market in Brazil during the forecast period.

Market Dynamics

Market Growth Drivers Analysis

The major cancer driver is the lifestyle risk factors such as alcohol consumption, obesity, smoking, unhealthy diet and lack of physical activity are in line with one third of all the deaths caused by cancer. Increase in government expenditure, R&D investment and presence of new drugs in pipeline also affects the market growth.

Market Restraints

Imbalance in the healthcare system, high risk of side effects associated with cancer treatment, risk related with high radiation exposure affecting use of CT scanners are likely to restrain the growth of the market.

COVID-19 impact on “Brazil Oncology Drugs Market” 

The COVID-19 pandemic has impacted the most crucial areas of the oncology drugs market. Pandemic has directly affected the supply of oncology drugs to cancer patients; not only is it difficult to administer chemotherapy and certain other treatments outside of a clinic, but the spread of coronavirus has reduced patients’ willingness and ability to access not just treatments, but trials for new medicines. COVID-19’s interference with the research and development of new treatments is one of the most significant blows that has been dealt to the oncology drugs market. However, this situation is expected to change post COVID-19 pandemic in the coming years.

Competitive Landscape

Key Players

Due to its huge potential and untapped market, many major players are trying to enter into the market. Some major companies in the market are Astrazeneca, Novartis, Pfizer and Roche. Other than these major players, there are companies which manufacture drugs for rare mutations in cancer, some of those are Blueprint medicines, Ignyta, Loxo Oncology etc.

One major emerging player in the market in Fiocruz, who recently released its oncology drug with immunobiological technology, and because of its subsidised rates due to government policies.

Products in Pipeline

14 December 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced results from the phase III POLARIX study showing that treatment with Polivy® (polatuzumab vedotin) in combination with MabThera®/Rituxan® (rituximab) plus cyclophosphamide, doxorubicin and prednisone (R-CHP) significantly reduced the risk of disease progression, relapse or death (progression-free survival; PFS) by 27% compared with the current standard-of-care, MabThera/Rituxan plus cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP), in people with previously untreated diffuse large B-cell lymphoma (DLBCL). Safety outcomes were consistent with those seen in previous trials and the safety profile was comparable for Polivy plus R-CHP versus R-CHOP

Notable Recent Deals

April 6, 2021 – PlantForm Corporation, PlantPraxis Biotecnologia and Bio-Manguinhos/Fiocruz (Health Ministry of Brazil) announced a collaborative research and development agreement to develop a biosimilar pembrolizumab for the Brazilian market.The original antibody drug, pembrolizumab, is widely used in immunotherapy to treat a variety of cancers including melanoma, lung cancer, head and neck cancer, and stomach cancer. This agreement advances PlantForm’s collaborations in Brazil to make affordable, effective cancer drugs available to millions of Brazilians

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario of Brazil Oncology Drugs Services

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN)announced that the U.S. Food and Drug Administration (FDA) has accepted for priority review the supplemental Biologics License Application (sBLA) for PD-1 inhibitor Libtayo® (cemiplimab-rwlc) to treat patients with recurrent or metastatic cervical cancer whose disease progressed on or after chemotherapy. The target action date for the FDA decision is January 30, 2022. The sBLA is also being reviewed under the FDA’s Project Orbis initiative, which will allow for concurrent review by participating health authorities in Australia, Brazil, Canada and Switzerland. Additional global regulatory submissions are planned, including in the European Union (EU) by the end of 2021.

1. Report Description of the Brazil Oncology Drugs Market
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. Brazil Oncology Drugs Market Executive Summary
2.1 Brazil Oncology Drugs Market – Industry Snapshot & key buying criteria, 2020-2027
2.2 Market Size, Growth Prospects, and Key findings
3. Market Dynamics of Brazil Oncology Drugs Market
3.1 Market Growth Drivers Analysis
3.1.1 Increasing lifestyle risk factors
3.1.2 Lack of physical activity
3.1.3 Increase in government expenditure, R&D investment
3.1.4 Presence of new drugs in pipeline
3.2 Market Restraints Analysis
3.3 Imbalance in the healthcare system
3.4 High risk of side effects associated with cancer treatment
3.5 Risk related with high radiation exposure affecting use of CT scanners
3.6 Covid-19 Market Impact Analysis
3.3.1 Negative impact on outcomes
4. Oncology Drugs Market Segmentation
4.1 By Therapy Type Analysis:
4.1.1 Chemotherapy
4.1.2 Immunotherapy
4.1.3 Target Therapy
4.1.4 Hormonal Therapy
4.1.5 Other Treatment Type
4.2 By Cancer Type Analysis:
4.2.1 Lung cancer
4.2.2 Prostate cancer
4.2.3 Colon and rectal cancer
4.2.4 Gastric cancer
4.2.5 Esophageal cancer
4.2.6 Liver cancer
4.2.7 Breast cancer
4.2.8 Others
4.3 By End User Analysis:
4.3.1 Hospital Pharmacies
4.3.2 Retail Pharmacies
4.3.3 Online Pharmacies
5. Brazil Oncology Drugs Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
6.2 Products in Pipeline
6.3 R&D Initiatives in Brazil Oncology Drugs Market
6.4 Notable recent deals in Brazil Oncology Drugs Market
6.4.1 Joint Ventures
6.4.2 Partnerships
6.4.3 Mergers &Acquisitions
6.4.4 Strategic divestments
7. Key Company Profiles
7.1 Astrazeneca Company Overview
Product & Services, Strategies & Financials
7.2 Novartis PLC Company Overview
Product & Services, Strategies & Financials
7.3 Pfizer AG Company Overview
Product & Services, Strategies & Financials
7.4 Roche Company Overview
Product & Services, Strategies & Financials
7.5 Bueprint medicines Ltd Company Overview
Product & Services, Strategies & Financials
7.6 Lgnyta Company Overview
Product & Services, Strategies & Financials
7.7 Loxo Oncology Company Overview
Product & Services, Strategies & Financials
7.8 Fiocruz Company Overview
Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
8.1 Pricing and Reimbursement scenario of Brazil Oncology Drugs Market
8.2 Government Initiatives / Intervention programs
9. Factors Driving Future Growth
9.1 New Trends and Development Brazil Oncology Drugs Market
9.2 Future Opportunities
10. Strategic Recommendations

Oncology Drugs Market Segmentation

By Therapy Type:

The therapy type available for cancer are chemotherapy, targeted therapy, immunotherapy and hormonal therapy. The most common type of treatment is the chemotherapy, but immunotherapy has some 47 new products in the pipeline, which are to be approved, paving the way for investment in this sector, this is popular because of less side effects during the treatment.

  • Chemotherapy
  • Immunotherapy
  • Target Therapy
  • Hormonal Therapy
  • Other Treatment Type

By Cancer Type:

The breast cancer segment revenue will be around USD 3.3 billion by the end of 2027. The major causes of increase in breast cancer incidence and prevalence rate are obesity, hormone imbalance, age-related risks, and replacement therapy. Moreover, the incidence of breast cancer in women is rising rapidly. For instance, it is estimated that, in 2020, nearly 66,280 new cases of women with breast cancer were reported, representing 29.7% of all types of cancer with an incidence of 43.7 per 100 thousand women. Also, in Brazil, malignant breast cancer is the most common type of cancer in women.

  • Lung cancer
  • Prostate cancer
  • Colon and rectal cancer
  • Gastric cancer
  • Esophageal cancer
  • Liver cancer
  • Breast cancer
  • Others

By Distribution Channel:

Based on the distribution channel, the market is segmented into retail pharmacies, hospital pharmacies and e-pharmacies. Among the three of them, hospital pharmacy holds the largest market share, but due to government initiative of taking healthcare online, e-pharmacy is an untapped market in the country.

  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements